MarketCap
Facebook
X
TelegramQuarterly report 2024-Q1
added 05-15-2024
VBI Vaccines DIO Ratio 2011-2026 | VBIV
Annual DIO Ratio VBI Vaccines
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 85.7 | 49.6 | 73.7 | 55.4 | 82.5 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 85.7 | 49.6 | 69.4 |
Quarterly DIO Ratio VBI Vaccines
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | 93 | 95.3 | 57.1 | - | 49.6 | 41.7 | 76.8 | - | 104 | 77.9 | 54.9 | - | 53.9 | 53 | 57.9 | - | 25.2 | 29.3 | 90.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 104 | 25.2 | 64 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B |  USA |
 |
Aptorum Group Limited
APM
|
4.89 | $ 0.88 | - | $ 6.47 M |  China |
 |
ACADIA Pharmaceuticals
ACAD
|
295 | $ 22.5 | -0.75 % | $ 3.73 B | USA |
 |
Galapagos NV
GLPG
|
0.915 | $ 27.55 | -3.08 % | $ 2.69 B |  Belgium |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M |  Canada |
 |
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | USA |
 |
Aquestive Therapeutics
AQST
|
120 | $ 4.07 | -0.61 % | $ 435 M | USA |
 |
Jaguar Health
JAGX
|
916 | $ 0.23 | -5.27 % | $ 536 K | USA |
 |
Arcutis Biotherapeutics
ARQT
|
185 | $ 22.56 | -3.13 % | $ 2.87 B | USA |
 |
KalVista Pharmaceuticals
KALV
|
203 | $ 26.71 | 38.8 % | $ 1.44 B | Britain |
 |
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.4 | -5.74 % | $ 373 M | Britain |
 |
Kamada Ltd.
KMDA
|
166 | $ 8.15 | - | $ 260 M |  Israel |
 |
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | Britain |
 |
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B |  Cayman-islands |